Health
Arthritis drug Tocilizumab reduces severe Covid mortality: study – Bangkok Post
PARIS – The arthritis drug tocilizumab reduces the risk of critically ill patients dying of Covid-19, according to results of a study on Thursday which experts…
PARIS – The arthritis drug tocilizumab reduces the risk of critically ill patients dying of Covid-19, according to results of a study on Thursday which experts welcomed as an “exciting” development.
The Britain-based RECOVERY research programme investigating Covid-19 treatments said their findings could have a significant effect on hospital survival rates during the pandemic.
The study included more than 2,000 patients who received the drug intravenously compared with nearly 3,000 who were given…
-
General21 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News21 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Noosa News20 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business23 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…